Nippon Shinyaku Drug Patent Portfolio
Nippon Shinyaku owns 1 orange book drug protected by 2 US patents Given below is the list of Nippon Shinyaku's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10870676 | Antisense nucleic acids | 31 Aug, 2031 | Active |
| US9079934 | Antisense nucleic acids | 31 Aug, 2031 | Active |
Latest Legal Activities on Nippon Shinyaku's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Nippon Shinyaku.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 05 Jun, 2024 | US10870676 |
| transaction for FDA Determination of Regulatory Review Period | 08 Dec, 2023 | US9079934 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US9079934 |
| Second letter to regulating agency to determine regulatory review period | 26 Jan, 2023 | US9079934 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Dec, 2022 | US9079934 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 21 Dec, 2022 | US9079934 |
|
Email Notification
Critical
| 21 Dec, 2022 | US9079934 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 14 Nov, 2022 | US10870676 |
|
Email Notification
Critical
| 14 Nov, 2022 | US10870676 |
|
Correspondence Address Change
Critical
| 30 Sep, 2022 | US10870676 |
| Letter from FDA or Dept of Agriculture re PTE application | 24 Aug, 2022 | US9079934 |
| Initial letter Re: PTE Application to regulating agency | 02 Mar, 2021 | US9079934 |
| Sequence Moved to Public Database | 22 Dec, 2020 | US10870676 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 22 Dec, 2020 | US10870676 |
|
Recordation of Patent Grant Mailed
Critical
| 22 Dec, 2020 | US10870676 |
Nippon Shinyaku Drug Patents' Oppositions Filed in EPO
Nippon Shinyaku drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on May 06, 2020, by Sarepta Therapeutics. This opposition was filed on patent number EP15199455A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP15199455A | May, 2020 | James Poole Limited | Revoked |
| EP15199455A | May, 2020 | Sarepta Therapeutics | Revoked |
Nippon Shinyaku's Family Patents
Nippon Shinyaku Drug List
Given below is the complete list of Nippon Shinyaku's drugs and the patents protecting them.
1. Viltepso
Viltepso is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10870676 | Antisense nucleic acids |
31 Aug, 2031
(6 years from now)
| Active |
| US9079934 | Antisense nucleic acids |
31 Aug, 2031
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Viltepso's drug page